EHR adoption may not yield gain in revenues

Article

Health care providers may not see a positive return on investment (ROI) after adopting electronic health record (EHR) systems, suggests a study that examined how physicians would fare financially after incorporating EHRs into their practices.

Health care providers may not see a positive return on investment (ROI) after adopting electronic health record (EHR) systems, suggests a study that examined how physicians would fare financially after incorporating EHRs into their practices.

Researchers analyzed survey data from 49 community practices in Massachusetts to project 5-year ROIs after implementation of EHR systems. They found that only 27% of practices would realize a positive ROI; the average physician would see a loss of $43,743. An additional 14% of practices would be ahead if they received the $44,000 federal meaningful-use incentive.

Those practices with positive ROIs used their EHRs to increase revenue by scheduling more office visits and seeing more patients, emphasizing accurate coding to reduce the number of rejected claims, and improving billing procedures. Nearly half the practices did not see savings because they continued to use paper-based medical records.

Current meaningful-use incentives appear to favor larger practices, and incentives alone may not guarantee smaller practices a positive ROI after EHR implementation. Researchers say that these smaller practices need to focus on additional changes that will help them improve their bottom lines.

Recent Videos
cUTI Roundtable: Discussing and diagnosing these difficult infections
Willough Jenkins, MD
Discussing health care sustainability, climate change, and WHO's One Health goal | Image credit: Provided by Shreya Doshi
Willough Jenkins, MD
Screening for and treating the metatarsus adductus foot deformity |  Image Credit: UNFO md ltd
Wendy Ripple, MD
Wendy Ripple, MD
Courtney Nelson, MD
DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.